Light Horse Therapeutics
PrivateLast Round
Series A
Jan 9, 2025
Total Funding Raised
$62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Light Horse Therapeutics is a biotechnology company that develops first-in-class small molecule therapeutics using a proprietary function-first gene editing platform to discover novel functional sites on disease-critical targets, with an initial focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Light Horse Therapeutics Comparables
Compare Light Horse Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexo Therapeutics | 87% | |
| Frontier Medicines | 81% | |
| Odyssey Therapeutics | 79% |
Light Horse Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2025 |
Key People
Founding team and executive leadership
Light Horse Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiho Ventures | Series A |
| Versant Ventures | Series A |
| Mubadala Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 45% MoM.
- Apr 18, 2026
Monthly visitors increased 46% MoM.
Light Horse Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Light Horse Therapeutics's valuation, stock price, and market status.
Is Light Horse Therapeutics a public or private company?
Light Horse Therapeutics is a private company.
What is the current stock price of Light Horse Therapeutics?
Light Horse Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Light Horse Therapeutics worth (valuation)?
Valuation information for Light Horse Therapeutics is not publicly available.
Can I buy Light Horse Therapeutics stock?
Light Horse Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Light Horse Therapeutics's last funding round?
Light Horse Therapeutics's most recent funding round was Series A on January 9, 2025.
Who are the main investors in Light Horse Therapeutics?
Key investors in Light Horse Therapeutics include Versant Ventures.
Will Light Horse Therapeutics IPO soon?
No public IPO plans have been announced for Light Horse Therapeutics.
How can I track Light Horse Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Light Horse Therapeutics's secondary market activity and sign up for updates.